Wyeth (WYE) agrees to be acquired by rival Pfizer (PFE) for $68B in cash and stock. Pfizer will borrow $22.5B to finance the acquisition and will cut its quarterly dividend to $0.16/share. Premarket: WYE +8.6%.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs